ZYME - Zymeworks Inc.

QQQ $ 472.49 $ -2.05 (-0.43 %)

DIA $ 416.26 $ -1.07 (-0.26 %)

SPY $ 562.20 $ -1.67 (-0.3 %)

TLT $ 99.62 $ -1.25 (-1.24 %)

GLD $ 235.53 $ -1.83 (-0.77 %)

Previous Close

$ 12.52

Open

$ 12.29

Bid

$ 12.52 x 200

Ask

-- x --

Day's Range

$ 12.29 - $ 12.74

52 Week Range

$ 6.02 - $ 13.14

Volume

431,507

Average Volume

Market Cap

788.71M

Beta (5Y Monthly)

$ 0.96

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-01-2024	06-30-2024	10-Q
2	05-02-2024	03-31-2024	10-Q
3	03-06-2024	12-31-2023	10-K
4	11-07-2023	09-30-2023	10-Q
5	08-10-2023	06-30-2023	10-Q
6	05-08-2023	03-31-2023	10-Q
7	03-07-2023	12-31-2022	10-K
8	11-08-2022	09-30-2022	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Neutral on ...
09/18/2024 11:07:39

HC Wainwright & Co. analyst Robert Burns reiterates Zymeworks (NASDAQ:ZYME) with a Neutral and maintains $10 price target.

Zymeworks Announced Two Presentations High...
09/18/2024 10:02:43

Stifel Maintains Buy on Zymeworks, Raises ...
08/02/2024 17:58:37

Stifel analyst Stephen Willey maintains Zymeworks (NASDAQ:ZYME) with a Buy and raises the price target from $20 to $21.

Zymeworks Files For Common Stock Offering ...
08/02/2024 11:06:16

-424B5

Zymeworks Announces Share Repurchase Progr...
08/01/2024 21:18:04

Zymeworks Inc. (NASDAQ:ZYME) (the "Company"), a clinical-stage biotechnology company developing a diverse pipeline of n...

Zymeworks Q2 2024 GAAP EPS $(0.49) Misses ...
08/01/2024 20:40:54

Zymeworks (NYSE:ZYME) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $0.07 by 80...

Zymeworks Appoints Leone Patterson As Exec...
07/25/2024 20:43:03

Zymeworks Says FDA Has Cleared Investigati...
07/22/2024 10:02:30

ZW191 is the Company's novel folate receptor-⍺ (FR⍺) targeted topoisomerase I inhibitor (TOPO1i) antibody-drug conjugate (A...

Market-Moving News for June 17th
06/17/2024 12:40:12

BBY: 4% | UBS Upgrades Best Buy Co to Buy, Raises Price Target to $106 ZYME: 13% | Zymeworks shares are trading higher after t...

Zymeworks shares are trading higher after ...
06/17/2024 11:45:40

FDA Clears Zymeworks' Investigational New ...
06/17/2024 10:03:10

Zymeworks Achieves Key Milestone with BLA ...
06/10/2024 10:02:52

Zymeworks Inc. (NASDAQ:ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional b...

Navigating 6 Analyst Ratings For Zymeworks
06/06/2024 12:00:39

HC Wainwright & Co. Reiterates Neutral on ...
06/06/2024 10:17:58

HC Wainwright & Co. analyst Robert Burns reiterates Zymeworks (NASDAQ:ZYME) with a Neutral and maintains $10 price target.

Zymeworks Stock: A Deep Dive Into Analyst ...
05/07/2024 13:00:42

HC Wainwright & Co. Reiterates Neutral on ...
05/07/2024 10:21:13

HC Wainwright & Co. analyst Robert Burns reiterates Zymeworks (NASDAQ:ZYME) with a Neutral and maintains $10 price target.

Citigroup Maintains Buy on Zymeworks, Lowe...
05/03/2024 21:57:07

Citigroup analyst Yigal Nochomovitz maintains Zymeworks (NASDAQ:ZYME) with a Buy and lowers the price target from $17 to $16.

Wells Fargo Maintains Overweight on Zymewo...
05/03/2024 18:04:42

Wells Fargo analyst Derek Archila maintains Zymeworks (NASDAQ:ZYME) with a Overweight and lowers the price target from $14 t...

Zymeworks Q1 2024 GAAP EPS $(0.42) Misses ...
05/02/2024 20:27:21

Zymeworks (NYSE:ZYME) reported quarterly losses of $(0.42) per share which missed the analyst consensus estimate of $(0.29) by ...

Zymeworks Presents New Data from Multiple ...
04/08/2024 10:05:55

Zymeworks Inc. (NASDAQ:ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional bi...